Journal
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Volume 1865, Issue 8, Pages 1982-1991Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbadis.2018.10.019
Keywords
Amyotrophic lateral sclerosis; Frontotemporal dementia; Parkinson's disease; Spinocerebellar ataxia; Epigenetics; Post translational modifications; Histones; Neurodegenerative disease; Neurodegeneration; Friedreich's ataxia
Funding
- Brooklyn College
- NIH NINDS Advanced Postdoctoral Career Transition Award [K22NS09131401]
- Graduate Center of the City University of New York
Ask authors/readers for more resources
Every year, neurodegenerative disorders take more than 5000 lives in the US alone. Cures have not yet been found for many of the multitude of neuropathies. The majority of amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and Parkinson's disease (PD) cases have no known genetic basis. Thus, it is evident that contemporary genetic approaches have failed to explain the etiology or etiologies of ALS/FTD and PD. Recent investigations have explored the potential role of epigenetic mechanisms in disease development. Epigenetics comprises heritable changes in gene utilization that are not derived from changes in the genome. A main epigenetic mechanism involves the post-translational modification of histones. Increased knowledge of the epigenomic landscape of neurodegenerative diseases would not only further our understanding of the disease pathologies, but also lead to the development of treatments able to halt their progress. Here, we review recent advances on the association of histone post-translational modifications with ALS, FTD, PD and several ataxias.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available